Indian Journal of Pharmacology Home 

RESEARCH ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2016  |  Volume : 48  |  Issue : 6  |  Page : 637--642

Genistein synergizes centchroman action in human breast cancer cells

Shweta Kaushik1, Hari Shyam2, Ramesh Sharma3, Anil K Balapure1 
1 Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh; Academy of Scientific and Innovative Research (AcSIR), Taramani, Chennai, Tamil Nadu, India
2 Division of Biochemistry, CSIR-Central Drug Research Institute; Centre for Advance Research, King George's Medical University, Lucknow, Uttar Pradesh, India
3 Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India

Correspondence Address:
Anil K Balapure
Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh; Academy of Scientific and Innovative Research (AcSIR), Taramani, Chennai, Tamil Nadu
India

Objectives: Despite the progress in the diagnosis and treatment of breast cancer, it remains a major health problem in women. Natural flavones along with chemotherapeutic agents enhance therapeutic response and minimize toxicity of chemical agents. Centchroman (CC) colloquially called as ormeloxifene, is a nonsteroidal oral contraceptive categorized as selective estrogen receptor modulator with anti-breast cancer activity. Genistein (GN), an isoflavone found mainly in soy products possesses anti-cancerous potential against a number of cancers including breast. The present study aims at investigating the combination of CC and GN in human breast cancer cell lines (HBCCs). Materials and Methods: Cytotoxic effect of CC and GN separately and in combination were assessed by sulforhodamine B (SRB) assay in MDA MB-231, MDA MB-468, MCF-7, T-47D HBCCs, and nontumorigenic human mammary epithelial cell (HMEC) MCF-10A. The drug interaction was analyzed using CompuSyn software through which combination index and dose reduction index were generated. Results: Combination of CC plus GN exerts significantly higher cytotoxicity compared to each drug per se in HBCCs, whereas HMEC-MCF-10A remains unaffected. Conclusion: On an overall basis, the drugs in combination enhanced cell killing in malignant cells. Therefore, the combination of CC with GN may offer a novel approach for the breast cancer.


How to cite this article:
Kaushik S, Shyam H, Sharma R, Balapure AK. Genistein synergizes centchroman action in human breast cancer cells.Indian J Pharmacol 2016;48:637-642


How to cite this URL:
Kaushik S, Shyam H, Sharma R, Balapure AK. Genistein synergizes centchroman action in human breast cancer cells. Indian J Pharmacol [serial online] 2016 [cited 2020 Aug 15 ];48:637-642
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=2016;volume=48;issue=6;spage=637;epage=642;aulast=Kaushik;type=0